Cargando…

Urinary CD 80 in Nephrotic Syndrome: A Biomarker to Distinguish Minimal Change Disease From Other Glomerular Diseases

Detalles Bibliográficos
Autor principal:	Mishra, Om P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610000/ https://www.ncbi.nlm.nih.gov/pubmed/33165400 http://dx.doi.org/10.1016/j.ekir.2020.09.027

Ejemplares similares

Urinary CD80 and Serum suPAR as Biomarkers of Glomerular Disease among Adults in Brazil
por: Zen, Renata de Cássia, et al.
Publicado: (2023)

Predictability of Urinary CD80 in the Relapse of Primary Nephrotic Syndrome
por: Liao, Juan, et al.
Publicado: (2017)

Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity
por: Gonzalez Guerrico, Anatilde M., et al.
Publicado: (2020)

Urinary indices in nephrotic syndrome
por: Sahay, M.
Publicado: (2011)

Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria
por: Isom, Robert, et al.
Publicado: (2019)

The level of urinary semaphorin3A is associated with disease activity in patients with minimal change nephrotic syndrome
por: Inoue-Torii, Akiko, et al.
Publicado: (2017)

Nephrotic syndrome due to minimal-change disease superimposed on anti-glomerular basement membrane antibody positive glomerulonephritis; a case report
por: Shibata, Yuko, et al.
Publicado: (2020)

Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features
por: Gong, Xiaojie, et al.
Publicado: (2023)

Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease
por: Lee, Hajeong, et al.
Publicado: (2016)

Tozinameran: Nephrotic syndrome and minimal change disease : case report
Publicado: (2022)

Outcomes of minimal change disease without nephrotic range proteinuria
por: Son, Hyung Eun, et al.
Publicado: (2023)

Are microRNA potential biomarkers in children with idiopathic nephrotic syndrome?
por: Parvex, Paloma
Publicado: (2018)

Urinary and plasma proteomics to discover biomarkers for diagnosing between diabetic nephropathy and minimal change nephrotic syndrome or membranous nephropathy
por: Araumi, Akira, et al.
Publicado: (2021)

Increased urinary CD80 excretion and podocyturia in Fabry disease
por: Trimarchi, H., et al.
Publicado: (2016)

Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria
por: Tanaka, Marenao, et al.
Publicado: (2020)

Usefulness of the cytokines expression of Th1/Th2/Th17 and urinary CD80 excretion in adult-onset minimal change disease
por: Chen, Ping, et al.
Publicado: (2020)

A Case of Nephrotic Syndrome With Minimal-Change Disease and Waldenstrom’s Macroglobulinemia
por: Grabe, Darren W., et al.
Publicado: (2013)

Minimal Change Disease: More Than a Podocytopathy?
por: Maas, Rutger J., et al.
Publicado: (2022)

The glomerular permeability factors in idiopathic nephrotic syndrome
por: Davin, Jean-Claude
Publicado: (2015)

Clinical Characteristics and Outcomes of Adults with Nephrotic Syndrome Due to Minimal Change Disease
por: Lionaki, Sophia, et al.
Publicado: (2021)

CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease
por: Teh, Yoong Mond, et al.
Publicado: (2021)

The utility of urinary CD80 as a diagnostic marker in patients with renal diseases
por: Minamikawa, Shogo, et al.
Publicado: (2018)

Using Existing Mobile Technology to Monitor Disease Activity: An Example in Childhood Nephrotic Syndrome
por: Eaton, Cyd K.
Publicado: (2019)

Tozinameran: Minimal change disease with nephrotic syndrome and acute kidney injury: case report
Publicado: (2021)

mRNA-1273: Nephrotic syndrome secondary to minimal change disease: case report
Publicado: (2021)

mRNA-1273: Nephrotic syndrome secondary to minimal change disease: case report
Publicado: (2021)

Tozinameran: De novo minimal change disease (MCD) and nephrotic syndrome: case report
Publicado: (2022)

Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change
por: de Vet, Henrica C, et al.
Publicado: (2006)

GLOMERULAR PERMEABILITY : II. FERRITIN TRANSFER ACROSS THE GLOMERULAR CAPILLARY WALL IN NEPHROTIC RATS
por: Farquhar, Marilyn G., et al.
Publicado: (1961)

Possible role for glomerular-derived angiotensinogen in nephrotic syndrome
por: Yamazaki, Mihoko, et al.
Publicado: (2016)

Quality of Life in Patients with Minimal Change Nephrotic Syndrome
por: Shutto, Yoshiko, et al.
Publicado: (2013)

Cerebral infarction in patient with minimal change nephrotic syndrome
por: Babu, A., et al.
Publicado: (2013)

Pathogenesis of minimal change nephrotic syndrome: an immunological concept
por: Kim, Seong Heon, et al.
Publicado: (2016)

Iliac Arterial Thrombosis in Minimal Change Nephrotic Syndrome
por: Nagayama, Yoshikuni, et al.
Publicado: (2022)

CD80 and CTLA-4 as diagnostic and prognostic markers in adult-onset minimal change disease: a retrospective study
por: Zhao, Bing, et al.
Publicado: (2018)

Extracorporeal Therapy for Idiopathic Nephrotic Syndrome
por: Au, Eric, et al.
Publicado: (2021)

Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra
por: Angeletti, Andrea, et al.
Publicado: (2021)

Screening for urinary biomarkers of steroid-resistant nephrotic syndrome in children
por: BAI, YONGQI, et al.
Publicado: (2013)

Primary glomerular disease in adults: pattern over decades,interpretation across the globe
por: Naqvi, Rubina
Publicado: (2015)

Anti-glomerular basement membrane disease with intense nephrotic syndrome: a new case report
por: Mami, Ikram, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bd42pdn5c3gngig6fskn9cnjdm